The content on this site is intended for healthcare professionals only
Princess Margaret Hospital and University of Toronto, Canada
Published: 28 Nov 2008
Views: 15156
Prof. Ian Tannock
Blood pressure and efficacy in patients with metastatic renal cell carcinoma receiving axitinib, from ESMO 2008
- Categories:
- Prostate & urology
Related Videos
Comparison of health access, lifestyle, prostate cancer knowledge, and screening...
Dr Orlando Rivera Colón - University of Central Florida, Florida, USA
25 Oct 2021
Advances in prostate cancer in the last 10 years and a glimpse to the future
Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono
21 Oct 2021
Cancer Health Disparities Special Issue - Editorial
Prof Folakemi Odedina - University of Florida, Tampa, USA
14 Oct 2021
Quality of life and safety in novel therapies for prostate cancer
Prof Heather Payne, Prof Alicia Morgans and Prof Bertrand Tombal
24 Sep 2021
Enzalutamide plus androgen deprivation therapy prolongs survival in men with met...
Prof Andrew Armstrong - Duke University, Durham, USA
24 Sep 2021
Adding abiraterone acetate plus prednisolone to standard therapy lengthens survi...
Prof Nick James - The Institute of Cancer Research, London, UK
23 Sep 2021
PARP inhibitors in prostate cancer: Case based testing and clinical decisions
Dr Neal Shore and Prof Fred Saad
20 Sep 2021
OncoAlert and ecancer - ESMO 2021 Day 4
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
20 Sep 2021
Abiraterone acetate plus prednisolone added to ADT + docetaxel, gives 25% reduct...
Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France
19 Sep 2021
